Volume 69, Issue 3, Pages (March 2016)

Slides:



Advertisements
Similar presentations
Volume 62, Issue 4, Pages (October 2012)
Advertisements

Volume 69, Issue 3, Pages (March 2016)
Volume 57, Issue 1, Pages (January 2010)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Testosterone Therapy in Men With Prostate Cancer
Volume 56, Issue 6, Pages (December 2009)
Volume 72, Issue 6, Pages (December 2017)
Systematic Review of the Efficacy and Safety of High-Intensity Focussed Ultrasound for the Primary and Salvage Treatment of Prostate Cancer  Marisa Warmuth,
Volume 53, Issue 4, Pages (April 2008)
Volume 62, Issue 5, Pages (November 2012)
Volume 64, Issue 6, Pages (December 2013)
Volume 71, Issue 1, Pages (January 2017)
Management of Acute and Chronic Retention in Men
Volume 61, Issue 5, Pages (May 2012)
Volume 67, Issue 4, Pages (April 2015)
Volume 63, Issue 1, Pages (January 2013)
Volume 67, Issue 3, Pages (March 2015)
Volume 64, Issue 4, Pages (October 2013)
Volume 61, Issue 2, Pages (February 2012)
Prostate Cancer Epidemic in Sight?
Volume 65, Issue 6, Pages (June 2014)
Volume 61, Issue 3, Pages (March 2012)
Volume 66, Issue 1, Pages (July 2014)
Volume 53, Issue 2, Pages (February 2008)
Tumour Grade, Treatment, and Relative Survival in a Population-based Cohort of Men with Potentially Curable Prostate Cancer  Sam Ladjevardi, Gabriel Sandblom,
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.
Volume 59, Issue 3, Pages (March 2011)
Volume 54, Issue 4, Pages (October 2008)
Elizabeth K. Bancroft, Rosalind A. Eeles
Prostate Cancer Detection: A View of the Future
Ongoing Gleason Grade Migration in Localized Prostate Cancer and Implications for Use of Active Surveillance  Adam B. Weiner, Ruth Etzioni, Scott E. Eggener 
Volume 68, Issue 3, Pages (September 2015)
Low-risk Prostate Cancer: Identification, Management, and Outcomes
Volume 69, Issue 6, Pages (June 2016)
Volume 69, Issue 3, Pages (March 2016)
Volume 60, Issue 4, Pages (October 2011)
Volume 65, Issue 3, Pages (March 2014)
Prostate Cancer Epidemic in Sight?
Volume 61, Issue 5, Pages (May 2012)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 53, Issue 4, Pages (April 2008)
Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia
Tillmann Loch, Pat Fox Fulgham  European Urology 
Volume 68, Issue 4, Pages (October 2015)
Volume 68, Issue 6, Pages (December 2015)
Volume 68, Issue 4, Pages (October 2015)
Is It Necessary to Detect All Prostate Cancers in Men with Serum PSA Levels
Volume 48, Issue 6, Pages (December 2005)
Volume 66, Issue 3, Pages (September 2014)
Volume 50, Issue 5, Pages (November 2006)
CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System
Volume 55, Issue 3, Pages (March 2009)
European Urology Oncology
European Urology Oncology
Testicular Cancer Variations in Time and Space in Europe
Volume 54, Issue 6, Pages (December 2008)
Volume 75, Issue 4, Pages (April 2019)
Volume 59, Issue 4, Pages (April 2011)
Volume 73, Issue 1, Pages (January 2018)
Volume 65, Issue 3, Pages (March 2014)
European Urology is “Your” Journal
Volume 75, Issue 4, Pages (April 2019)
Jonathan S. Brajtbord, Michael S. Leapman, Matthew R. Cooperberg 
Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized.
Role of Transurethral Resection of the Prostate and Biopsy of the Peripheral Zone in the Same Session after Repeated Negative Biopsies in the Diagnosis.
Volume 69, Issue 1, Pages (January 2016)
Volume 52, Issue 6, Pages (December 2007)
Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson 
Volume 53, Issue 2, Pages (February 2008)
Volume 54, Issue 3, Pages (September 2008)
Presentation transcript:

Volume 69, Issue 3, Pages 419-425 (March 2016) Prebiopsy Multiparametric Magnetic Resonance Imaging for Prostate Cancer Diagnosis in Biopsy-naive Men with Suspected Prostate Cancer Based on Elevated Prostate- specific Antigen Values: Results from a Randomized Prospective Blinded Controlled Trial  Panu P. Tonttila, Juha Lantto, Eija Pääkkö, Ulla Piippo, Saila Kauppila, Eveliina Lammentausta, Pasi Ohtonen, Markku H. Vaarala  European Urology  Volume 69, Issue 3, Pages 419-425 (March 2016) DOI: 10.1016/j.eururo.2015.05.024 Copyright © 2015 European Association of Urology Terms and Conditions

Fig. 1 Consolidated Standards of Reporting Trials flow diagram of the study. f/t=free/total; MP=multiparametric; MRI=magnetic resonance imaging; PSA=prostate-specific antigen; TRUS=transrectal ultrasound; TURP=transurethral resection of the prostate. European Urology 2016 69, 419-425DOI: (10.1016/j.eururo.2015.05.024) Copyright © 2015 European Association of Urology Terms and Conditions